Supply Chain Management White Papers
Economic Benefits of EPC in Pharmaceuticals
Overview The pharmaceutical industry is an area where there is significant activity around EPC and understanding how best to apply the technology to improve efficiency and reduce losses. Cap Gemini Ernst & Young (CGE&Y) in collaboration with the Auto-ID Center has developed a business case for the adoption of Auto-ID in the pharmaceutical industry. This white paper identifies not only the opportunities available within the supply chain, it also includes benefits within the drug development and clinical trials process, as well as improvements to patient safety and effects on gray market activities.
| Publisher | Auto-ID Center | File Format | PDF, requires Acrobat Rdr 5 |
|---|---|---|---|
| Date Published | October 2003 | Downloads | 16 |
| Format | White Papers | ||
| Topics | |||



